F423S (p.Phe423Ser) variant of GCK (Hexokinase-4)

F423S (p.Phe423Ser) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.69 / 1. The record also includes structural context.

F423S (p.Phe423Ser) variant details